Pinnacle Associates’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-29,500
Closed -$237K 838
2024
Q3
$237K Sell
29,500
-1,319
-4% -$8.69K ﹤0.01% 740
2024
Q2
$215K Sell
30,819
-2,830
-8% -$21.4K ﹤0.01% 763
2024
Q1
$357K Buy
33,649
+4,149
+14% +$36.3K 0.01% 657
2023
Q4
$237K Sell
29,500
-100
-0.3% -$728 ﹤0.01% 751
2023
Q3
$243K Sell
29,600
-300
-1% -$2.59K ﹤0.01% 714
2023
Q2
$239K Sell
29,900
-2,700
-8% -$19.9K ﹤0.01% 737
2023
Q1
$264K Buy
32,600
+8,550
+36% +$68.7K 0.01% 656
2022
Q4
$151K Sell
24,050
-6,300
-21% -$44K ﹤0.01% 724
2022
Q3
$209K Sell
30,350
-29,400
-49% -$204K ﹤0.01% 683
2022
Q2
$500K Buy
59,750
+35,675
+148% +$499K 0.01% 514
2022
Q1
$550K Sell
24,075
-400
-2% -$9.78K 0.01% 535
2021
Q4
$676K Sell
24,475
-1,150
-4% -$30.8K 0.01% 513
2021
Q3
$714K Sell
25,625
-900
-3% -$25.5K 0.01% 500
2021
Q2
$778K Sell
26,525
-200
-0.7% -$6.06K 0.01% 477
2021
Q1
$848K Sell
26,725
-7,400
-22% -$217K 0.02% 442
2020
Q4
$710K Buy
34,125
+5,125
+18% +$95.6K 0.01% 453
2020
Q3
$451K Sell
29,000
-2,450
-8% -$42.2K 0.01% 509
2020
Q2
$575K Buy
31,450
+400
+1% +$7.05K 0.01% 468
2020
Q1
$481K Buy
31,050
+17,000
+121% +$410K 0.01% 478
2019
Q4
$420K Sell
14,050
-50
-0.4% -$1.3K 0.01% 561
2019
Q3
$308K Sell
14,100
-550
-4% -$12.6K 0.01% 598
2019
Q2
$369K Hold
14,650
0.01% 575
2019
Q1
$362K Buy
14,650
+4,500
+44% +$107K 0.01% 576
2018
Q4
$187K Buy
10,150
+2,200
+28% +$52.3K ﹤0.01% 656
2018
Q3
$204K Buy
+7,950
New +$182K ﹤0.01% 673

Other funds holding BHC

Pinnacle Associates's BHC Position: Q4 2024 in Review

Pinnacle Associates sold out of Bausch Health (BHC) in Q4 2024, closing a stake of 29,500 shares — an estimated $237K sold.

Pinnacle Associates first reported a position in BHC in Q3 2018 and held it in 25 quarters. The position peaked at $848K in Q1 2021. 225 funds tracked by Wall St. Rank hold BHC as of Q4 2024.

  • Pinnacle Associates reported no remaining Bausch Health position as of Q4 2024 after selling out during the quarter.
  • Pinnacle Associates sold 29,500 Bausch Health shares in Q4 2024, an estimated $237K.
  • Pinnacle Associates first reported a position in Bausch Health in Q3 2018 and held it in 25 quarters.
  • Pinnacle Associates's Bausch Health position peaked at $848K in Q1 2021.
  • 225 funds tracked by Wall St. Rank held Bausch Health as of Q4 2024.

Based on Pinnacle Associates's 13F filing for Q4 2024, filed 14 Feb 2025.